Cosmos Pharmaceutical Co., Ltd. has approved an increase in the year-end dividend to 44.5 yen for FY2026, bringing the total annual dividend to 82 yen. The dividend will be paid out from retained earnings, effective August 10, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3349","jir_company_name":"Cosmos Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/3349-20260713-02.pdf","jir_short_summary":"Cosmos Pharmaceutical Co., Ltd. has approved an increase in the year-end dividend to 44.5 yen for FY2026, bringing the total annual dividend to 82 yen. The dividend will be paid out from retained earnings, effective August 10, 2026.","jir_summary":"### Dividend Details\nCosmos Pharmaceutical Co., Ltd. has approved an increase in the FY2026 year-end dividend to 44.5 yen, with the total annual dividend set at 82 yen. The dividend will be paid from retained earnings, with an effective date of August 10, 2026. Compared to the previous fiscal year, the dividend amount has increased, reinforcing shareholder returns.\n\n### Dividend Policy and Impact on Shareholders\nThe company\u2019s basic policy is to provide stable and continuous dividends, prioritizing shareholder returns while maintaining internal reserves. The increase in dividend aligns with shareholder expectations and aims to enhance the attractiveness of the stock. The company will continue to adhere to its profit distribution policy, aiming for sustainable shareholder returns.","jir_financial_highlights":"Earnings Per Share: 44 yen 50 sen (YoY +7 yen)\nAnnual Dividend: 82 yen (YoY +12 yen)\nTotal Dividend Amount: 3,526 million yen (Unknown)","jir_category":"","jir_hashtags":"#CosmosPharmaceutical, #Dividend, #JapanStocks","jir_key_figures":"Total Dividend Amount: 3,526 million yen\nEarnings Per Share: 44 yen 50 sen\nAnnual Dividend: 82 yen","jir_meta_title":"\u3010Cosmos Pharmaceutical\u3011Dividend increased to 44.5 yen | FY2026 May","jir_meta_description":"Cosmos Pharmaceutical has increased its FY2026 year-end dividend to 44.5 yen, with the annual dividend totaling 82 yen. The total dividend amount is 3,526 million yen, effective August 10, 2026.","jir_og_title":"\u3010Cosmos Pharmaceutical\u3011Dividend Increase | FY2026 May","jir_og_description":"Cosmos Pharmaceutical has increased its FY2026 year-end dividend to 44.5 yen, with the annual dividend at 82 yen. It is strengthening shareholder returns.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7750,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"dividend","footnotes":""},"sector":[],"importance":[],"class_list":["post-79886","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n